Markets:

Overview

News

Currencies

International

Treasuries

Baxter International (NY:BAX)

16.12 +0.32 (+2.03%)

Streaming Delayed Price Updated: 11:03 AM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

25 26 Next >

Peering Into Baxter Intl's Recent Short Interest ↗

March 27, 2025

Via Benzinga

Baxter to Host Annual Meeting of Stockholders in Virtual Format

March 26, 2025

From Baxter International Inc.

Via Business Wire

What's going on in today's after hours session: S&P500 movers ↗

March 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.

Via Chartmill

Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings?

March 11, 2025

Over the past six months, Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P 500 has climbed by 1.5%. This might have...

Via StockStory

Topics Stocks

Demystifying Baxter Intl: Insights From 4 Analyst Reviews ↗

February 26, 2025

Via Benzinga

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday ↗

March 10, 2025

Via Benzinga

What To Expect From CooperCompanies’s (COO) Q4 Earnings

March 05, 2025

Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings

March 04, 2025

From Baxter International Inc.

Via Business Wire

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

February 28, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified...

Via StockStory

“From Left For Dead To Loved Again” Stock Market (and Sentiment Results)… ↗

February 27, 2025

Healthcare is the top-performing sector in the market, up 7.31% and outperforming the S&P 500 by 4.2x. Looks like the rumors of its death were indeed GREATLY EXAGGERATED.

Via Talk Markets

Topics Stocks Stocks / Equities

Baxter to Present at Barclays 27th Annual Global Healthcare Conference

February 25, 2025

From Baxter International Inc.

Via Business Wire

Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment

February 25, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,...

Via StockStory

Exploring the top movers within the S&P500 index during today's session. ↗

February 24, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

February 24, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers.

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

February 20, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook ↗

February 20, 2025

Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.

Via Benzinga

Topics Earnings

Which S&P500 stocks are moving before the opening bell on Thursday? ↗

February 20, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars

February 20, 2025

Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue...

Via StockStory

Baxter Reports Fourth-Quarter and Full-Year 2024 Results

February 20, 2025

From Baxter International Inc.

Via Business Wire

Baxter Earnings: What To Look For From BAX

February 19, 2025

Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know.

Via StockStory

Baxter to Present at TD Cowen 45th Annual Health Care Conference

February 18, 2025

From Baxter International Inc.

Via Business Wire

Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference

February 17, 2025

From Baxter International Inc.

Via Business Wire

Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day

February 13, 2025

From Baxter International Inc.

Via Business Wire

What To Expect From Baxter’s (BAX) Q4 Earnings

February 12, 2025

Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Baxter Declares Quarterly Dividend

February 11, 2025

From Baxter International Inc.

Via Business Wire

Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million ↗

February 07, 2025

Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.

Via Benzinga

Baxter Announces CEO Retirement and Appointment of COO

February 03, 2025

From Baxter International Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.